Key result
Pre-hospital bivalirudin was non-inferior to heparin plus GPI for residual ST-segment deviation one hour after primary PCI.
Why the study?
Does pre-hospital bivalirudin provide non-inferior ST-segment resolution compared to pre-hospital heparin plus GPIs in STEMI patients undergoing primary PCI?
RCT (n=871)
Randomized
Yes
Does pre-hospital bivalirudin provide non-inferior ST-segment resolution compared to pre-hospital heparin plus GPIs in STEMI patients undergoing primary PCI?
Pre-hospital bivalirudin is non-inferior to pre-hospital heparin plus GPIs for myocardial reperfusion assessed by ST-segment resolution in STEMI patients undergoing primary PCI.
Answers are grounded in this paper and cite their sources.
Supports GPI-sparing anticoagulation in STEMI PCI; extends pre-hospital bivalirudin options versus heparin regimens.
BACKGROUND: Myocardial reperfusion after primary percutaneous coronary intervention (PCI) can be assessed by the extent of post-procedural ST-segment resolution. The European Ambulance Acute Coronary Syndrome Angiography (EUROMAX) trial compared pre-hospital bivalirudin and pre-hospital heparin or enoxaparin with or without GPIIb/IIIa inhibitors (GPIs) in primary PCI. This nested substudy was performed in centres routinely using pre-hospital GPI in order to compare the impact of randomized treatments on ST-resolution after primary PCI. METHODS: Residual cumulative ST-segment deviation on the single one hour post-procedure electrocardiogram (ECG) was assessed by an independent core laboratory and was the primary endpoint. It was calculated that 762 evaluable patients were needed to show non-inferiority (85% power, alpha 2.5%) between randomized treatments. RESULTS: A total of 871 participated with electrocardiographic data available in 824 patients (95%). Residual ST-segment deviation one hour after PCI was 3.8±4.9 mm versus 3.9±5.2 mm for bivalirudin and heparin+GPI, respectively ( p=0.0019 for non-inferiority). Overall, there were no differences between randomized treatments in any measures of ST-segment resolution either before or after the index procedure. CONCLUSIONS: Pre-hospital treatment with bivalirudin is non-inferior to pre-hospital heparin + GPI with regard to residual ST-segment deviation or ST-segment resolution, reflecting comparable myocardial reperfusion with the two strategies.
No takes yet. Share an insight, caveat, or question.
Hof et al. (2015) conducted an RCT in ST-segment elevation myocardial infarction (STEMI) (n=871). Pre-hospital bivalirudin vs. Pre-hospital heparin + GPI was evaluated on Residual cumulative ST-segment deviation on the single one hour post-procedure ECG (p=0.0019 for non-inferiority). Pre-hospital bivalirudin was non-inferior to heparin plus GPI for residual ST-segment deviation one hour after primary PCI.
Synapse has enriched 10 related papers. Consider them for comparative context: